The global FISH Probe Market size is expected to reach USD 1.04 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 6.8% during the forecast period. Increasing global population prone to target diseases and demand for accurate and effective diagnostics of these diseases are the factors attributed to the growth. Increasing use of fluorescent in situ hybridization (FISH) probes in vitro diagnosis of various infectious diseases is expected to create growth opportunities in near future.
In addition, supportive government initiatives, rising
healthcare expenditure and awareness pertaining to the benefits associated with
FISH probe technique are expected to drive the market growth during forecast
period. Furthermore, technological advancement in Chromogenic In Situ
Hybridization (CISH) such as higher storage time for analyzed samples for long
duration studies is expected to fuel the demand.
FISH is most commonly used for the detection of genetic
diseases such as Angelman syndrome, Prader-Willi syndrome, chronic myelogenous
leukemia, Down’s syndrome, Velocardiofacial syndrome, 22q13 deletion syndrome,
acute lymphoblastic leukemia, and cri-du-chat. The genetic disease segment led
the overall market in 2018. The probe does not require live cells and can
quantify automatically as compared to the conventional cytogenetics, and is
more convenient and effective. This factor is anticipated to propel the segment
growth. According to a publication from the Centers for Disease Control and
Prevention (CDC) in 2018, Down’s syndrome was the most common genetic disorders
with almost one in every 700 new newborns affected by the disorder.
Request a sample copy or view summary of this report@ https://www.grandviewresearch.com/industry-analysis/fluorescent-in-situ-hybridization-probe-market
Further key findings from the study suggest:
- Companion
diagnostics is expected to command the largest market share of end use
segment. Used in personalized medicine, it includes medical decision,
products, and practices based on patient’s genetic, clinical, and genomic
information
- In
oncology, major companion diagnostics are based on the FISH owing to
higher reliability, sensitivity, accuracy, and procedure reproducibility,
which are less affected by analytical variables and tissue fixation as
compared to immunohistochemistry
- miRNA is
expected to be the fastest growing RNA segment, driven by factors such as
increasing R&D and extensive usage in cancer detection
- Asia
Pacific is expected to showcase lucrative growth over the forecast period
due to rising per capita healthcare expenditure, improving healthcare
facilities, and demand for IVD testing for disease detection
- Increasing
R&D activities pertaining to cancer diagnostics and investment by
private and government sector into biotech industry in Asia Pacific are
the factors responsible for the growth
- Key
players operating in the Fluorescent In Situ Hybridization (FISH) probe
market include Oxford Gene Technology; Mirus Bio LLC; Agilent
Technologies; Perkin Elmer Inc.; Genemed Biotechnologies Inc.; Horizon
Diagnostics; BioDot Inc.; Sigma Aldrich; Life Science Technologies; GSP
Research Institute Co., Ltd; Abnova Corporation; Biosearch Technologies; F
Hoffman La Roche AG; Bio Care Medical LLC; EXIQON; and Affymetrix Panomics
About Us:
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, the company offers market intelligence
studies ensuring relevant and fact-based research across a range of industries
including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment